Cibc World Markets Corp Takes $96,000 Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Cibc World Markets Corp acquired a new position in LifeStance Health Group, Inc. (NASDAQ:LFST) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 13,053 shares of the company’s stock, valued at approximately $96,000.

Several other large investors have also modified their holdings of LFST. Blue Trust Inc. lifted its position in LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after acquiring an additional 2,122 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of LifeStance Health Group by 31.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock worth $169,000 after purchasing an additional 5,767 shares during the period. The Manufacturers Life Insurance Company lifted its position in shares of LifeStance Health Group by 10.5% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock worth $572,000 after purchasing an additional 7,798 shares during the last quarter. Rhumbline Advisers lifted its position in shares of LifeStance Health Group by 4.5% during the 4th quarter. Rhumbline Advisers now owns 195,581 shares of the company’s stock worth $1,441,000 after purchasing an additional 8,487 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in LifeStance Health Group by 0.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,113,499 shares of the company’s stock valued at $8,206,000 after buying an additional 9,046 shares during the last quarter. 85.50% of the stock is owned by institutional investors.

Analysts Set New Price Targets

LFST has been the subject of a number of research analyst reports. William Blair reiterated an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $8.63.

Insider Buying and Selling

In other news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the transaction, the insider now owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 6.60% of the stock is owned by company insiders.

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST opened at $6.77 on Friday. The firm has a market capitalization of $2.60 billion, a PE ratio of -26.04 and a beta of 1.27. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 1-year low of $4.64 and a 1-year high of $8.61. The business’s 50 day moving average is $7.63 and its 200-day moving average is $7.35.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.